Samsung Union Dispute Escalates Over Semiconductor Bonus Vote 
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions 
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations 
SK Hynix Joins $1 Trillion Club as AI Chip Demand Fuels Stock Surge 
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments 
Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs 
Meta AI Push Could Add $26 Billion in Revenue by 2027, Wolfe Research Says 
PDG Explores $1 Billion Sale of China Data Center Assets 
SpaceX Starship V3 Test Flight Boosts IPO Momentum Ahead of Historic Market Debut 
MongoDB Q1 FY2027 Earnings Beat Expectations, Raises Full-Year Outlook 
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion 
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand 
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand 
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026 
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure 
Blindness is an unfortunate impairment that affects millions around the world, but advanced medical technology offers hope. 10 patients who suffer from a form of blindness called Retinitis pigmentosa will be given the chance to have their sight restored via the installation of bionic eyes. This is the next frontier of medical science where science fiction finally becomes scientific fact.
The project will be conducted using the Argus® II Retinal Prosthesis System, which is a tandem of computer relay and camera sensors installed on a pair of glasses. As the system’s website explains, it basically works by having two electronic setups communicate with each other in order to restore vision for the patients.
“A miniature video camera housed in the patient's glasses captures a scene,” the website’s bionic eye section reads. “The video is sent to a small patient-worn computer (i.e., the video processing unit – VPU) where it is processed and transformed into instructions that are sent back to the glasses via a cable. These instructions are transmitted wirelessly to an antenna in the retinal implant. The signals are then sent to the electrode array, which emits small pulses of electricity. These pulses bypass the damaged photoreceptors and stimulate the retina's remaining cells, which transmit the visual information along the optic nerve to the brain, creating the perception of patterns of light.”
Before the Argus II program, patients who suffered from Retinitis pigmentosa had no hope for treatment, which effectively doomed them to a state of blindness forever, Futurism reports. Treatment will be delivered in groups, with five of the patients going to Manchester Royal Eye Hospital and the other five going to Moorfields Eye Hospital.
Their treatment will start in 2017 and if proven successful, the treatment could be made available to the estimated 16,000 patients who suffer from the impairment in the UK alone. Global delivery will likely take some time as well.
